Wednesday, 20 February 2013

Application in oncology


1.4 Application in oncology

Since recent developments, especially the increased skills of interventional
radiologists, there is an awakened interest in unique selective radionuclide therapy.
Many kinds of radiolabeled particles and radionuclides have been tested for local
treatment of a variety of tumours in organs, including liver, lung, tongue, spleen and
soft tissue of extremities. The purpose of this treatment is the superselective
application of suitable radioactive (high energetic β-emitters) particles to deliver high
doses to the tumour, with as little surrounding tissue damage as possible. These new
embolization methods are extremely important particularly for cancers with an
extremely poor prognosis and without other adequate therapies, such as primary and
metastatic malignancies of the liver.

No comments:

Post a Comment